The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of Formula (I) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.
本发明涉及一种新型CCR2(CC
趋化因子受体2)拮抗剂的
化学式(I),以及它们用于提供治疗疾病和病症的药物,特别是肺部疾病如哮喘和慢性阻塞性肺病。